Alle verbonden artikelen

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Auteurs : Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, Van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S
Jaar : 2014
Journal : Lancet Oncol
Volume : 15(4)
Pagina's : 406-14

Myeloperoxidase Oxidized LDL Interferes with Endothelial Cell Motility through miR-22 and Heme Oxygenase 1 Induction: Possible Involvement in Reendothelialization of Vascular Injuries.

Auteurs : Daher J, Martin M, Rousseau A, Nuyens V, Fayyad-Kazan H, Van Antwerpen P, Courbebaisse G, Martiat P, Badran B, Dequiedt F, Zouaoui Boudjeltia K, Vanhamme L
Jaar : 2014
Journal : Mediators Inflamm.
Volume : 2014(null)
Pagina's : 134635

Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.

Auteurs : Van Damme M, Crompot E, Meuleman N, Mineur P, Dessars B, El Housni H, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2014
Journal : Epigenetics
Volume : 9(10)
Pagina's : 1374-81

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.

Auteurs : Fumagalli D, Blanchet-Cohen A, Brown D, Desmedt C, Gacquer D, Michiels S, Rothé F, Majjaj S, Salgado R, Larsimont D, Ignatiadis M, Maetens M, Piccart-Gebhart M, Detours V, Sotiriou C, Haibe-Kains B
Jaar : 2014
Journal : BMC Genomics
Volume : 15(1)
Pagina's : 1008

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.

Auteurs : Rothé F, Laes JF, Lambrechts D, Smeets D, Vincent D, Maetens M, Fumagalli D, Michiels S, Drisis S, Moerman C, Detiffe JP, Larsimont D, Awada A, Piccart-Gebhart M, Sotiriou C, Ignatiadis M
Jaar : 2014
Journal : Ann Oncol
Volume : 25(10)
Pagina's : 1959-65

A microRNA profile of human CD8.

Auteurs : Jebbawi F, Fayyad-Kazan H, Merimi M, Lewalle P, Verougstraete JC, Leo O, Romero P, Burny A, Badran B, Martiat P, Rouas R
Jaar : 2014
Journal : J Transl Med
Volume : 12(1)
Pagina's : 218

Multicenter implementation of geriatric assessment in Belgian patients with cancer: A survey on treating physicians' general experiences and expectations.

Auteurs : Kenis C, Heeren P, Bron D, Decoster L, Moor R, Pepersack T, Langenaeken C, Rasschaert M, Jerusalem G, Van Rijswijk R, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2014
Journal : J Geriatr Oncol
Volume : 5(4)
Pagina's : 431-8

Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.

Auteurs : Chalandon Y, Passweg JR, Guglielmi C, Iacobelli S, Apperley J, Schaap NP, Finke J, Robin M, Fedele R, Bron D, Yakoub-Agha I, van Biezen A, de Witte T, Kröger N, Olavarria E
Jaar : 2014
Journal : Haematologica
Volume : 99(9)
Pagina's : 1492-8

Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization.

Auteurs : Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, Meuleman N, Bron D, Lagneaux L
Jaar : 2014
Journal : Stem Cells Dev.
Volume : 23(19)
Pagina's : 2390-2400

International study on inter-reader variability for circulating tumor cells in breast cancer.

Auteurs : Ignatiadis M, Riethdorf S, Bidard FC, Vaucher I, Khazour M, Rothé F, Metallo J, Rouas G, Payne RE, Coombes RC, Teufel I, Andergassen U, Apostolaki S, Politaki E, Mavroudis D, Bessi S, Pestrin M, Di Leo A, Campion M, Reinholz M, Perez E, Piccart-Gebhart M, Borgen E, Naume B, Jimenez J, Aura CM, Zorzino L, Cassatella MC, Sandri MT, Mostert B, Sleijfer S, Kraan J, Janni W, Fehm T, Rack B, Terstappen L, Repollet M, Pierga JY, Miller C, Sotiriou C, Michiels S, Pantel K
Jaar : 2014
Journal : Breast Cancer Res
Volume : 16(2)
Pagina's : R43

Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-? secreted by activated human CD4 lymphocytes.

Auteurs : Fayyad-Kazan H, Hamade E, Rouas R, Najar M, Fayyad-Kazan M, El Zein N, Eldirani R, Hussein N, Fakhry M, Al-Akoum C, Burny A, Martiat P, Badran B
Jaar : 2014
Journal : Hum Immunol
Volume : 75(7)
Pagina's : 677-85

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

Auteurs : Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, + collaborators (among others :, Ravoet C
Jaar : 2014
Journal : Leuk. Res.
Volume : 38(5)
Pagina's : 557-63

Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.

Auteurs : Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Desmedt C, Piccart-Gebhart M, Loibl S, Denkert C, Smyth MJ, Joensuu H, Sotiriou C
Jaar : 2014
Journal : Ann Oncol
Volume : 25(8)
Pagina's : 1544-50

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial.

Auteurs : Willemze R, Suciu S, Meloni G, Labar B, Marie JP, Halkes CJ, Muus P, Mistrik M, Amadori S, Specchia G, Fabbiano F, Nobile F, Sborgia M, Camera A, Selleslag DL, Lefrère F, Magro D, Sica S, Cantore N, Beksac M, Berneman Z, Thomas X, Melillo L, Guimaraes JE, Leoni P, Luppi M, Mitra ME, Bron D, Fillet G, Marijt EW, Venditti A, Hagemeijer A, Mancini M, Jansen J, Cilloni D, Meert L, Fazi P, Vignetti M, Trisolini SM, Mandelli F, de Witte T
Jaar : 2014
Journal : J. Clin. Oncol.
Volume : 32(3)
Pagina's : 219-28

Pulmonary Malignancies” “Pulmonary complications of HIV. Edited by Charles Feldman, Eva Polverino, Julio A. Ramirez. ERS/Monograph 66 (chapt 14)

Auteurs : Sculier JP, Meuleman N, Meert AP, Berghmans T
Jaar : 2014
Journal : Book
Volume : chapt 14
Pagina's : 186-198

Microvesicles and Cancer.

Auteurs : Azerad MA, Debaugnies F, Demulder A, Bron D, Efira A
Jaar : 2013
Journal : Belgian J Hematology
Volume : 4
Pagina's : 1

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Auteurs : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Jaar : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pagina's : 1155-60

Reply to Z. Blumenfeld et al.

Auteurs : Demeestere I, Brice P, Peccatori FA, Kentos A, Gaillard I, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(29)
Pagina's : 3722-3

Ibrutinib : a major breakthrough in the treatment of CLL and other lymphoproliferative disorders.

Auteurs : Bron D
Jaar : 2013
Journal : Belgian J Hematology
Volume : 4(3)
Pagina's : 102-105

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer.

Auteurs : Loi S, Michiels S, Lambrechts D, Fumagalli D, Claes B, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Piccart-Gebhart M, Joensuu H, Sotiriou C
Jaar : 2013
Journal : J. Natl. Cancer Inst.
Volume : 105(13)
Pagina's : 960-967